Anti-CD25 Treg targeting antibodies sparing IL-2 signaling promote regression of established glioblastoma tumors and innate cell activation.
Ontology highlight
ABSTRACT: Treg depletion in mouse GBM using the anti-CD25 antibody, led to tumor regression and improved survival. We performed single cell RNA sequencing on tumor, lymphoid and myeloid samples from treated and untreated samples
ORGANISM(S): Mus musculus
PROVIDER: GSE218013 | GEO | 2025/05/12
REPOSITORIES: GEO
ACCESS DATA